Pricing Log in Create free account

Amarin Corporation PLC (AMRN) vs Nasus Pharma Ltd. (NSRX)

Amarin Corporation PLC and Nasus Pharma Ltd. are both Drug Manufacturers General companies. Amarin Corporation PLC is the larger, with a market value of $244.0M against $34.1M — 7.2× the size. Across the 8 metrics below, Nasus Pharma Ltd. leads on 5 and Amarin Corporation PLC on 3.

Valuation

Metric AMRN NSRX Drug Manufacturers General median
P/E n/m — 26.51
P/S 1.37 — 3.49
P/B 0.54 n/m 5.28
Price to free cash flow 6.46 n/m 21.67
EV/EBITDA 2.15 n/m 14.73
EV/Sales (0.36) n/m 4.15
Earnings yield (7.91%) — 2.41%
Free cash flow yield 15.49% 0.00% 4.07%

Profitability

Metric AMRN NSRX Drug Manufacturers General median
Gross margin 40.94% — 73.01%
Operating margin (18.19%) — 18.34%
Net margin (10.87%) — 7.31%
Free cash flow margin 21.29% 0.00% 18.56%
Return on equity (4.24%) 0.00% 5.80%
Return on assets (2.96%) 0.00% 2.28%
Return on invested capital (16.57%) 0.00% 6.26%

Growth

Metric AMRN NSRX Drug Manufacturers General median
Revenue growth (TTM) (22.33%) — 6.72%
EPS growth (last fiscal year) 53.25% (231.82%) 21.81%
Revenue growth, 5-year CAGR (19.04%) — 4.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AMRN NSRX Drug Manufacturers General median
Debt to equity 0.00 0.00 0.62
Current ratio 3.50 8.77 1.39
Net debt to EBITDA 6.42 0.26 1.15

Dividend

Metric AMRN NSRX Drug Manufacturers General median
Dividend yield — — 2.32%
Payout ratio — — 0.59

Size

Metric AMRN NSRX Drug Manufacturers General median
Market cap 244.00m 34.08m 129.04b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack